![Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d3a9e875-4541-471f-8af0-9479d554128b/jgm3015-fig-0007-m.jpg)
Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library
![Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/eef7817d-c8a4-48ad-a229-1e786816eb97/jgm3015-fig-0006-m.jpg)
Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library
![Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c3d54b40-4874-432b-bc40-9cf7c1f05b4c/jgm3015-fig-0005-m.jpg)
Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library
![Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI) | Gene Therapy Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI) | Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41434-021-00284-4/MediaObjects/41434_2021_284_Fig1_HTML.png)
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI) | Gene Therapy
![BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and Secondary Efficacy Endpoints in One-Year Data Set - Jan 10, 2021 BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and Secondary Efficacy Endpoints in One-Year Data Set - Jan 10, 2021](https://mma.prnewswire.com/media/1417431/Biomarin.jpg?w=2700)
BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and Secondary Efficacy Endpoints in One-Year Data Set - Jan 10, 2021
![Turning genes into medicines—what have we learned from gene therapy drug development in the past decade? | Nature Communications Turning genes into medicines—what have we learned from gene therapy drug development in the past decade? | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-19507-0/MediaObjects/41467_2020_19507_Fig1_HTML.png)
Turning genes into medicines—what have we learned from gene therapy drug development in the past decade? | Nature Communications
![Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/28822890-49c3-4805-a410-144939554034/jgm3015-fig-0001-m.jpg)
Gene therapy clinical trials worldwide to 2017: An update - Ginn - 2018 - The Journal of Gene Medicine - Wiley Online Library
![BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and Secondary Efficacy Endpoints in One-Year Data Set - Jan 10, 2021 BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and Secondary Efficacy Endpoints in One-Year Data Set - Jan 10, 2021](https://mma.prnewswire.com/media/1417431/Biomarin.jpg?p=twitter)